Overnight (1 mg) dexamethasone suppression testing reliably distinguishes non-cushingoid obesity from Cushing's syndrome

Liddle, 1960, Tests of pituitary adrenal suppressibility in the diagnosis of Cushing's syndrome, J Clin Endocrinol Metab, 20, 1539, 10.1210/jcem-20-12-1539 Meikle, 1982, Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone, Clin Endocrinol, 16, 401, 10.1111/j.1365-2265.1982.tb00733.x Bleiben, 1989, Overnight dexamethasone suppression test: normal responses and the diagnosis of Cushing's syndrome, Steroids, 54, 185, 10.1016/0039-128X(89)90093-7 McHardy-Young, 1967, Single dose dexamethasone suppression test for Cushing's syndrome, Br Med J, 2, 740, 10.1136/bmj.2.5554.740 Crapo, 1979, Cushing's syndrome: a review of diagnostic tests, Metabolism, 28, 955, 10.1016/0026-0495(79)90097-0 Dyrenfurth, 1960, Studies in patients with adrenocortical hyperfunction: I. Effects of corticotrophin on levels of corticosteroids, 17-ketosteroids and aldosterone, J Clin Endocrinol, 20, 735, 10.1210/jcem-20-5-735 Nugent, 1965, Diagnosis of Cushing's syndrome, Arch Intern Med, 116, 172, 10.1001/archinte.1965.03870020012006 Atkinson, 1989, A weight related intravenous dexamethasone suppression test distinguishes obese controls from patients with Cushing's syndrome, Acta Endocrinol (Copenh), 120, 753, 10.1530/acta.0.1200753 Cronin, 1990, The overnight dexamethasone test is a worthwhile screening procedure, Clin Endocrinol, 33, 27, 10.1111/j.1365-2265.1990.tb00462.x Connolly, 1968, Single-dose dexamethasone suppression in normal subjects and hospital patients, Br Med J, 2, 665, 10.1136/bmj.2.5606.665 Eddy, 1973, Cushing's syndrome: a prospective study of diagnostic methods, Am J Med, 55, 621, 10.1016/0002-9343(73)90184-8 Tucci, 1967, Rapid dexamethasone suppression test for Cushing's syndrome, JAMA, 199, 379, 10.1001/jama.199.6.379